To evaluate and compare the incidence of xerostomia (“dry mouth”) in head and neck (H&N) cancer patients treated with intensity-modulated proton therapy (IMPT) and intensity-modulated radiation therapy (IMRT), across unilateral (UT) and bilateral (BT) treatme...
Author profile
Laurine Schnelzauer, MS
University of Miami
Parotid Dose–Response and Xerostomia Risk In Head and Neck Cancer Treated with IMPT and IMRT
Poster Program · Therapy Physics
External Validation of a Machine Learning Model for Oral Mucositis Prediction In Proton Therapy
Proton therapy’s ability to spare normal tissue generally lowers complications, making it an attractive treatment option for head and neck (HN) cancer. Yet, oral mucositis, one of the most frequent and clinically relevant toxicities, occurs in approximately 6...
Poster Program · Therapy Physics
Moving Beyond a Generic Rbe: Experimental Validation of GSM2 for Clinical Proton Therapy
Proton therapy plans are optimized by relating the delivered dose to an equivalent photon dose using the Relative Biological Effectiveness (RBE). Clinically, a constant RBE of 1.1 is assumed, despite evidence that RBE varies along the proton beam path. Accura...
Poster Program · Therapy Physics